TY - JOUR T1 - Evaluation on the Effectiveness on the Implementation of WHO-CST Programme in Hong Kong: A RCT Protocol JF - medRxiv DO - 10.1101/2021.05.17.21257327 SP - 2021.05.17.21257327 AU - Paul Wai-Ching Wong AU - Siu-Lun Chow Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/24/2021.05.17.21257327.abstract N2 - Developmental delays/disorders in young children are identified as a public health priority. WHO and Autism Speaks co-designed a training programme titled “WHO-Caregiver Skills Training” (WHO-CST) which aims at providing training for caregivers whose children are with possible symptoms of Autism spectrum disorder (ASD) symptoms and pervasive developmental disorders (PDD), so that they can learn better strategies on managing the daily lives of their children and foster better communication between the parent-children dyad. The WHO-CST programme is currently implemented in more than 30 regions worldwide and it started in Hong Kong from 2018. As the programme is newly developed, only a few studies tried to evaluate the effectiveness of the programme in qualitative approaches, or in quantitative approach with relatively small sample (e.g. n < 10). In the present study, our team, who is responsible for the implementation and evaluation of the WHO-CST programme in Hong Kong, attempt to assess the effectiveness of the training in WHO-CST under a randomized controlled trial (RCT) design with about 120 eligible caregivers who will be randomly assigned in experimental and control groups. Our measurement will include the Joint Engagement Rating Inventory (JERI) developed by experts in WHO to gauge how parents engage their children in a 10-minute video recording their dyadic interaction and behaviors in a defined play setting. A set of other measurements on the caregiver’s experience of using intervention skills and their enhancement of knowledges will also be measured. We hypothesize that caregivers in treatment group will have better growth in scores of both JERI and measurements of other outcome than the wait-list control group’s after the 12-week WHO-CST training, and also persistence of skill and knowledge level should also be found after a 30-day follow-up test.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR2000034585Funding StatementThe Hong Kong Jockey Club (HKJC) Charities Trust has earmarked funds to pioneer a project entitled "JC A-Connect: Jockey Club Autism Support Network" (JC A-Connect) to enhance support for children with ASD and their families and schools in Hong Kong. The WHO-CST programme and this study are parts of the JC A-Connect project and the HKJC Charities Trust did not involve in any design of the research studies, data collection, management, analysis nor interpretation of data. The Family Support Team of the JC A-Connect project is subordinated the Faculty of Social Science, The University of Hong Kong. The team is responsible for delivering the clinical services filling the syllabus and standard of WHO-CST, training trainers to deliver the WHO-CST program at community level, collecting and analyzing data for the evaluation of WHO-CST program in Hong Kong. The authors are staff of the team.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Before the commencement of the study, ethical approval has already been obtained from the Human Research Ethics Committee, the University of Hong Kong.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be available at July 2020. The use of data will be subject to the agreement with the WHO side since a team of WHO staff has been involved in the development of this study. ER -